Bortniker, Lacktman Comment on Novel Teledermatology Program in Massachusetts
20 November 2017
Partner Nate Lacktman and Senior Counsel Alexis Finkelberg Bortniker were quoted in a mHealth Intelligence article, “Telemedicine Success Often Hinges on Aligning Providers and Payers,” about the launch of a teledermatology program at 22 remote sites in Massachusetts.
Bortniker said the best way to establish such a program is to approach individual health plans and look for partnerships. “You have to be out there, and you have to find the right payer,” she said. “You have to do your homework and be prepared to convince them.”
Lacktman cited other deliberate efforts by providers to align with payers and embrace cooperation on coverage and reimbursement. “Too many sit back on their heels and say, ‘We’re not getting reimbursed,” he said. “But by communicating with [commercial payers], they have a chance to align their visions.”
Bortniker said the best way to establish such a program is to approach individual health plans and look for partnerships. “You have to be out there, and you have to find the right payer,” she said. “You have to do your homework and be prepared to convince them.”
Lacktman cited other deliberate efforts by providers to align with payers and embrace cooperation on coverage and reimbursement. “Too many sit back on their heels and say, ‘We’re not getting reimbursed,” he said. “But by communicating with [commercial payers], they have a chance to align their visions.”
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”